NIH-funded research R01 grant

Biomarkers and Biotypes to Predict Early Psychosis Course in Bipolar Disorder

Official title: 1/5 - Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)

Funded at Ut Southwestern Medical Center · NIH-11412655 · Data updated 2026-11-12

Researchers will use brain and cognitive markers to help predict how early psychosis in bipolar disorder patients will progress and what treatments might help best.

More Psychosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startAugust 15, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$287,000
NIH project number5R01MH127179-05
Project IDNIH-11412655 on NIH RePORTER

Who could benefit from this research

Could help

Young adults (approximately 18–35) with early psychosis who are enrolled in coordinated specialty care at participating sites.

Less likely to help

Individuals outside the age range, without early psychosis, or not receiving CSC services may not directly benefit.

What this research studies

This project will follow 320 young people with early psychosis who are receiving coordinated specialty care, collecting biomarkers such as EEG, eye movement data, and neurocognitive tests along with clinical information. The team will apply a biomarker-based Biotype classification previously developed in a larger psychosis sample to these patients and track their outcomes at 1, 6, and 12 months. By combining biomarker data with clinical and demographic factors, they aim to predict illness trajectory and tailor treatment plans within CSC clinics at five sites, including UT Southwestern. The work could help clinicians forecast who is likely to recover quickly, who may need more intensive intervention, and how to personalize care in the early stages of illness.

Why it matters

Potential benefit: If successful, patients could receive more precise and timely treatment plans that improve recovery and functioning.

How similar studies have gone: Biotype-based biomarker approaches have been replicated in broader psychosis samples, supporting potential applicability to early-stage cases.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Tamminga, Carol a — Ut Southwestern Medical Center
  • Study coordinator: Tamminga, Carol a

Related research

Other NIH-funded projects on the same topics.

  • Psychosis in diverse settings across the world

    This project studies how psychotic disorders show up and respond to treatment in adults with diverse backgrounds, including populations in Africa, the Caribbean, and other Global South settings.

    NIH research Suny Downstate Medical Center · Brooklyn, United States · NIH-11592428

  • Psychosis in Diverse Settings: Understanding Symptoms and Treatment Across Global South

    A human-facing study will look at how psychotic disorders present and respond to treatment in adults from Africa, the Caribbean, and other Global South settings, using genetic and clinical data.

    NIH research Suny Downstate Medical Center · Brooklyn, United States · NIH-11592427

  • A new online brain-scan-style tool to spot early psychosis risk

    A new online-based set of tasks and a computer model aims to identify people at high risk for developing psychosis earlier and more accurately.

    NIH research Northwestern University · Chicago, United States · NIH-11590585

  • Genetic clues for early-onset psychosis in Latino youth

    This project looks at the genes of young people with early-onset psychosis and compares them with similar youths without psychosis to find genetic factors that contribute to the illness.

    NIH research Boston Children's Hospital · Boston, United States · NIH-11554752

  • Biomarkers to tailor rehab for Veterans with schizophrenia

    A clinician-scientist is developing a brain-based biomarker to guide personalized rehabilitation for Veterans with schizophrenia.

    NIH research VA San Diego Healthcare System · San Diego, United States · NIH-11552825

  • Computational analysis of facial expression in early psychosis

    Aims to develop computer-based measures of facial expression in people at risk for or with schizophrenia to help track symptoms and guide future trials.

    NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11539126

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.